Sign In
5 Jun 2020 07:00
Oncimmune Holdings plc
("Oncimmune" or the "Company")
Director/PDMR's Dealing
Oncimmune Holdings plc (AIM: ONC.L), the leading global immunodiagnostics group, was informed that, on 4 June 2020, dealings in the Company's ordinary shares of £0.01 each in the Company ("Ordinary Shares") by the following Director / PDMRs had occurred:
- Meinhard Schmidt, Non-Executive Chairman, together with his wife and PCA, Tatiana Schmidt, acquired in aggregate 13,000 Ordinary Shares at a weighted average price of £1.885 per share
- Tim Bunting, Non-Executive Director, acquired 150,000 Ordinary Shares at a weighted average price of £1.192 per share
- Adam Hill, Chief Executive Officer, acquired 8,481 Ordinary Shares at a price of £1.179 per share
- Matthew Hall, Chief Financial Officer, acquired 1,272 Ordinary Shares at a price of £1.179 per share
- Ron Kirschner, General Counsel and Company Secretary, acquired 1,652 Ordinary Shares at a price of £1.204 per share
Director/PDMR/ PCA | No. of Ordinary Shares acquired | Resulting interest | Resulting % holding |
Meinhard Schmidt / Tatiana Schmidt | 13,000 | 31,000 | 0.05% |
Tim Bunting | 150,000 | 2,956,717 | 4.7% |
Adam Hill | 8,481 | 40,913 | 0.06% |
Matthew Hall | 1,272 | 11,935 | 0.02% |
Ron Kirschner | 1,652 | 1,652 | 0.003% |
This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Meinhard Schmidt / Tatiana Schmidt | |||
2
| Reason for the notification | ||||
a)
| Position/status
| Non-executive Chairman / PCA | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Oncimmune Holdings plc | |||
b)
| LEI | 213800HCYIWT6YPI1I02 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each
| |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b)
| Nature of the transaction | Purchase of shares | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume | ||||
£1.17 | 8,000 | ||||
£1.21 | 5,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 13,000 shares Weighted average price of £1.885 | ||||
- Price | |||||
e)
| Date of the transaction | 4 June 2020 | |||
f)
| Place of the transaction | London stock exchange, AIM | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Timothy Bunting | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Non-executive Director | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name
| Oncimmune Holdings plc | |||
b)
| LEI | 213800HCYIWT6YPI1I02 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each
| |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b)
| Nature of the transaction
| Purchase of shares | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume | ||||
£1.195 | 60,000 | ||||
£1.19 | 90,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 150,000 shares Weighted average price of £1.192 | ||||
- Price | |||||
e)
| Date of the transaction | 4 June 2020 | |||
f)
| Place of the transaction | London stock exchange, AIM | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Dr Adam Mark Hill | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Executive Officer | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Oncimmune Holdings plc | |||
b)
| LEI | 213800HCYIWT6YPI1I02 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each
| |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b)
| Nature of the transaction
| Purchase of shares | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume | ||||
£1.179 | 8,481 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e)
| Date of the transaction | 4 June 2020 | |||
f)
| Place of the transaction
| London stock exchange, AIM | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Matthew Hall | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Financial Officer | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Oncimmune Holdings plc | |||
b)
| LEI | 213800HCYIWT6YPI1I02 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each
| |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b)
| Nature of the transaction | Purchase of shares | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume | ||||
£117.9 | 1,272 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e)
| Date of the transaction | 4 June 2020 | |||
f)
| Place of the transaction | London stock exchange, AIM | |||
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Ron Kirschner | |||
2
| Reason for the notification
| ||||
a)
| Position/status | General Counsel and Company Secretary | |||
b)
| Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a)
| Name | Oncimmune Holdings plc | |||
b)
| LEI | 213800HCYIWT6YPI1I02 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each
| |||
Identification code | ISIN: GB00BYQ94H38 | ||||
b)
| Nature of the transaction | Purchase of shares | |||
c)
| Price(s) and volume(s) | ||||
Price | Volume | ||||
£1.204 | 1,652 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | Same as above | ||||
- Price | |||||
e)
| Date of the transaction | 4 June 2020 | |||
f)
| Place of the transaction | London stock exchange, AIM | |||
For further information:
Oncimmune Holdings plc
Ron Kirschner, General Counsel and Company Secretary
contact@oncimmune.com
Follow the stocks
